David Hysong

David is the founder and Chief Executive Officer of SHEPHERD and the Executive Director of the SHEPHERD Foundation. He is a Forbes 30 Under 30 honoree, Charles River Research Models in Drug Discovery Award Winner, and Spotlight Health Scholar at the Aspen Institute. David previously founded an NGO that worked with refugee children, worked as an undercover investigator against the sexual enslavement of children in Southeast Asia, and was in the training pipeline for Special Operations in the U.S. Military until he was diagnosed with Adenoid Cystic Carcinoma in 2015. David combined the fearlessness, determination, and desire to save the lives of others that had marked his previous endeavors to found SHEPHERD with one goal in mind — to save the life of every rare cancer patient. David holds a B.A. in Economics, Philosophy and French Literature from Transylvania University, a M.A.L.A. in Intellectual History from St. John’s College, a M.Div from Harvard University in Religion, Ethics & Politics, and is currently completing his Executive MBA through the Owner/President Management Program at Harvard Business School.